Abstract
PURPOSE: To quantify the retinal thickness and the refractive error of the healthy human eye during hyperglycemia by means of optical coherence tomography (OCT) and Hartmann-Shack aberrometry. METHODS: Hyperglycemia was induced in five healthy subjects who were given a standard oral glucose tolerance test (OGTT) after a subcutaneous injection of somatostatin. Main outcome parameters were the central, pericentral and peripheral thickness of the fovea, measured by means of optical coherence tomography (OCT3). Ocular refractive error was determined with Hartmann-Shack aberrometry. Measurements at baseline and during maximal hyperglycemia were analyzed, and a change was considered clinically significant if the difference between the measurements exceeded the threshold of 50 microm for retinal thickness and 0.2 D for refractive error. RESULTS: During hyperglycemia (mean blood glucose level at baseline: 4.0 mmol/l; mean maximal blood glucose level: 18.4 mmol/l) no significant changes could be found in the central, pericentral, or peripheral foveal thickness in any of the five subjects. One of the subjects had a hyperopic shift of 0.4 D, but no significant change in refractive error was found in any of the other subjects. CONCLUSIONS: The present study shows that in healthy subjects induced hyperglycemia does not affect retinal thickness, but it can cause a small hyperopic shift of refraction.